High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-related Acute Respiratory Distress Syndrome: A Multicenter and Randomized Open-label Clinical Trial

enthalten in: bioRxiv.org | 2022

von Maskin, L. | Bonelli, I. | Olarte, G. | +10

Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis

enthalten in: bioRxiv.org | 2022

von Lee, T. | Bortolussi-Courval, �. | Belga, S. | +5

PBPK modelling of dexamethasone in patients with COVID-19 and liver disease

enthalten in: bioRxiv.org | 2022

von Montanha, M. | Cottura, N. | Booth, M. | +7

Clinical characteristics of Chilean patients with rheumatic diseases and COVID-19: data from the Covid-19 Global Rheumatology Alliance physician-reported registry

enthalten in: bioRxiv.org | 2022

von Martínez, O. | Valenzuela, F. | Ibáñez, S.

Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure

enthalten in: bioRxiv.org | 2022

von Gavriilidis, E. | Antoniadou, C. | Chrysanthopoulou, A. | +16

Neuropathic symptoms with SARS-CoV-2 vaccination

enthalten in: bioRxiv.org | 2022

von Safavi, F. | Gustafson, L. | Walitt, B. | +9

Modeling COVID-19 disease biology to identify drug treatment candidates

enthalten in: bioRxiv.org | 2022

von Jessen, W. | Gaisenband, S. | Quintanilla, M. | +4

Interleukin-6 as a predictor of early weaning from invasive mechanical ventilation in patients with acute respiratory distress syndrome

enthalten in: bioRxiv.org | 2022

von Sakai, K. | Nishii, M. | Saji, R. | +3

Combination of Baricitinib plus Remdesivir and Dexamethasone improves time to recovery and mortality among hospitalized patients with severe COVID-19 infection

enthalten in: bioRxiv.org | 2022

von Perez-Gutierrez, V. | Shah, V. | Afzal, A. | +8

Emerging Therapies for COVID-19: the value of information from more clinical trials

enthalten in: bioRxiv.org | 2022

von Dijk, S. | Krijkamp, E. | Kunst, N. | +3